Position in AZN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$2,031,279,814
New position
Shares Held
10,299,563
first reported quarter
Ownership
0.664%
of shares outstanding
% of Portfolio
4.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $3,896,027,978 across 10 Drug Manufacturers - General names. AZN ranks #1 (52.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
10,299,563 | $2,031,279,814 | |
| 2 | LLY |
ELI LILLY & Co
|
656,585 | $603,907,185 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,896,154 | $348,378,364 | |
| 4 | JNJ |
Johnson & Johnson
|
1,202,690 | $293,985,543 | |
| 5 | ABBV |
AbbVie Inc.
|
1,351,717 | $293,984,930 | |
| 6 | AMGN |
Amgen Inc
|
281,362 | $98,997,219 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
571,333 | $79,626,680 | |
| 8 | PFE |
Pfizer Inc
|
2,823,465 | $79,282,897 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,031,279,814 | 10,299,563 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||